Dec 15, 2023

VetStem’s 2023 Year in Review

Posted by Bob under VetStem

We can hardly believe 2023 is coming to an end! This was an exciting year for VetStem. We launched a new product and spent much of the year promoting that product at numerous trade shows across the United States. As our final blog of the year, we wanted to share some highlights from the last 12 months at VetStem. So, without further ado, here is VetStem’s 2023 year in review!

  • In late 2022, we began developing our newest product: PrecisePRP, a donor-derived off-the-shelf platelet-rich plasma for dogs and horses. We spent much of early 2023 finalizing the details of manufacturing, marketing, and all of the many pieces that come with developing a novel product such as this.
  • In February, we attended our first of many veterinary conferences in Las Vegas, NV. Western Vet Conference is one of the largest shows in the industry and it was the first time we began previewing the upcoming PrecisePRP.
  • In March, we announced a major expansion of our manufacturing and R&D facilities. We spent much of the year developing these facilities which are comprised of 13,765 square feet of class A biotech space. These facilities have been/will be used for internal VetStem projects, manufacturing for our sister company, Personalized Stem Cells, and for contract manufacturing of new veterinary biologics.
  • In April, VetStem sponsored a dry lab at the annual IVAPM Pain Management Forum for the second year in a row. Veterinarians at this forum have a particular interest in multi-modal pain management and were excited to learn about the upcoming PrecisePRP.
  • In August, we announced the soft launch of PrecisePRP, which is currently still undergoing the FDA review process but is available at a discounted price in exchange for outcome data.
  • August also saw the VetStem Sales and Marketing team in Kansas City, MO for the annual Fetch DVM360 conference. We sponsored three of the Fetch shows this year and spoke about platelet-rich plasma options at each show.
  • In September, VetStem sponsored a first of its kind stem cell workshop supporting wildlife conservation. The Stem Cell Technology for Genetic Rescue Workshop was held on September 17-20 in La Jolla, CA. Dr. Harman was among 45 global leaders in stem cell science, brought together to share their experience and expertise and to discuss how stem cell technology can further wildlife conservation efforts.
  • Shortly after the workshop, Dr. Harman attended the annual North American Veterinary Regenerative Medicine Association (NAVRMA) conference in Kona, HI. This conference brings together some of the greatest minds in regenerative veterinary medicine.
  • In early October, the Sales and Marketing team was back on the road. We did two shows back-to-back: Fetch Coastal in Atlantic City, NJ where we spoke about PRP and the American Association of Feline Practitioners (AAFP) conference in Memphis, TN where we sponsored two talks on feline medicine.
  • In late November/early December, the Sales and Marketing team wrapped up a busy year of conferences at the annual American Associate of Equine Practitioners (AAEP) conference in San Diego, CA and the final Fetch DVM360 conference in Long Beach, CA. At both shows, Dr. Harman spoke about PRP and stem cell therapy.
  • In our final press release of the year, we announced that a settlement was reached in a multi-year lawsuit regarding patent infringement. VetStem owns numerous patents and while we are dedicated to the development of innovative stem cell treatments and technology, we are also committed to protecting and enforcing our intellectual property rights. This was a big win for us and a great way to close out the year!

So, there you have it. Another year in the books. It was an exciting year for us and, as always, we couldn’t do what we do without the support of our veterinary and pet owner clients. We hope that you and your loved ones have a wonderful holiday season, and we look forward to seeing what 2024 has in store for VetStem!

Share

Comments are closed.